These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2821680)
1. Persistent coinfection of T lymphocytes with HTLV-II and HIV and the role of syncytium formation in HIV-induced cytopathic effect. Montefiori DC; Mitchell WM Virology; 1987 Oct; 160(2):372-8. PubMed ID: 2821680 [TBL] [Abstract][Full Text] [Related]
2. Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic. Montefiori DC; Mitchell WM Virology; 1986 Dec; 155(2):726-31. PubMed ID: 3024409 [TBL] [Abstract][Full Text] [Related]
3. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024 [TBL] [Abstract][Full Text] [Related]
5. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion. Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634 [TBL] [Abstract][Full Text] [Related]
6. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line. Getchell JP; Heath JL; Hicks DR; Sporborg C; McGrath CR; Kalyanaraman VS J Clin Microbiol; 1986 Apr; 23(4):737-42. PubMed ID: 2422205 [TBL] [Abstract][Full Text] [Related]
7. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Popovic M; Sarngadharan MG; Read E; Gallo RC Science; 1984 May; 224(4648):497-500. PubMed ID: 6200935 [TBL] [Abstract][Full Text] [Related]
9. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487 [TBL] [Abstract][Full Text] [Related]
10. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Harada S; Koyanagi Y; Yamamoto N Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081 [TBL] [Abstract][Full Text] [Related]
11. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Sodroski J; Goh WC; Rosen C; Tartar A; Portetelle D; Burny A; Haseltine W Science; 1986 Mar; 231(4745):1549-53. PubMed ID: 3006244 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Zack JA; Cann AJ; Lugo JP; Chen IS Science; 1988 May; 240(4855):1026-9. PubMed ID: 2835813 [TBL] [Abstract][Full Text] [Related]
13. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552 [TBL] [Abstract][Full Text] [Related]
14. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. Harada S; Koyanagi Y; Yamamoto N Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616 [TBL] [Abstract][Full Text] [Related]
15. A molecular clone of HTLV-III with biological activity. Fisher AG; Collalti E; Ratner L; Gallo RC; Wong-Staal F Nature; 1985 Jul 18-24; 316(6025):262-5. PubMed ID: 2410792 [TBL] [Abstract][Full Text] [Related]
16. Chromosome studies in HTLV-I, -II, and HIV-1, -2 cell lines infected in vivo and in vitro. Whang-Peng J; Chen YM; Knutsen T; Zhao WP; Tsai S J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):930-40. PubMed ID: 8315577 [TBL] [Abstract][Full Text] [Related]
17. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934 [TBL] [Abstract][Full Text] [Related]
18. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Mitsuya H; Popovic M; Yarchoan R; Matsushita S; Gallo RC; Broder S Science; 1984 Oct; 226(4671):172-4. PubMed ID: 6091268 [TBL] [Abstract][Full Text] [Related]
19. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS. Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784 [TBL] [Abstract][Full Text] [Related]
20. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo. Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]